Section 3

Operators may place on the market the following derived products: cosmetic products as defined in Article 1(1) of Directive 76/768/EEC; active implantable medical devices as defined in Article 1(2)(c) of Directive 90/385/EEC; medical devices as defined in Article 1(2)(a) of Directive 93/42/EEC; in vitro diagnostic medical devices as defined in Article 1(2)(b) of Directive 98/79/EC; veterinary medicinal products as defined in Article 1(2) of Directive 2001/82/EC; medicinal products as defined in Article 1(2) of Directive 2001/83/EC. The import, collection and movement of animal by-products and derived products destined for establishments or plants for the manufacture of the derived products referred to in Article 33 and the manufacture of those derived products shall be carried out in accordance with the Community legislation referred to in that Article. Unused material from such establishments or plants shall be disposed of in accordance with that legislation. However, this Regulation shall apply where the Community legislation referred to in Article 33 does not provide for conditions controlling potential risks to public and animal health in accordance with the objectives of this Regulation.

← art_32__para_3__text_2 · All articles · Artikel 33 →

Source: EUR-Lex (Cellar) · retrieved 2026-10-31 · Text as adopted (Official Journal); later amendments are not incorporated in this text.